Overview

• Glim Skin's founders pitched their Glim90 skincare device on 'Die Höhle der Löwen,' seeking €300,000 for 10% equity, but all investors declined due to concerns over valuation, testing, and readiness.
• The Glim90 uses cold plasma technology to reduce skin blemishes and redness; a pre-show test reported promising results for mild issues but lacked data on severe acne.
• Following the show's rejection, the founders developed a market-ready version of the device and launched online sales, attracting over 1,000 customers.
• The startup secured a six-figure angel investment and a convertible loan from NRW.BANK to support its growth and distribution plans.
• Glim Skin plans to expand beyond its online shop to retail partnerships with perfumeries, drugstores, and pharmacies to scale sales.